Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Cancer|September 8, 2011
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectinCristina Mansilla, Pedro Berraondo, Maika Durantez, et al.Molecular Therapy. Methods & Clinical Development|June 2, 2015
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infectionAintzane Zabaleta, Delia D'Avola, Itziar Echeverria, et al.NPJ Breast Cancer|November 26, 2024
Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapySonia Pernas, Esther Sanfeliu, Guillermo Villacampa, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2015
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR StimulationTeresa Lozano, Lorea Villanueva, Maika Durántez, et al.Journal for Immunotherapy of Cancer|June 26, 2020
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigensLaura Arribillaga, Iciar Echeverria, Viriginia Belsue, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trialEva Ciruelos, Tomás Pascual, Guillermo Villacampa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2026
Pembrolizumab and Paclitaxel in HR+/HER2- Breast Cancer with HER2-Enriched or Basal-Like SubtypesBenedetta Conte, Fara Brasó-Maristany, Tomás Pascual, et al.Journal of the National Cancer Institute|September 28, 2021
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell MalignanciesCarlos A Garcia-Prieto, Lorea Villanueva, Alberto Bueno-Costa, et al.Pageof 2